Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an ...

The Ann Arbor staging system is used to divide patients into limited- (I/II) or advanced- (III/IV) stage disease. Recommended staging work-up includes a complete blood count with differential, renal ...